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Abstract. During vertebrate embryogenesis, the 
muscle-specific helix-loop-helix protein myogenin is 
expressed in muscle cell precursors in the developing 
somite myotome and limb bud before muscle fiber for- 
mation and is further upregulated during myogenesis. 
We show that cis-acdng DNA sequences within the 5' 
flanking region of the mouse myogenin gene are suf- 
ficient to direct appropriate temporal, spatial, and 
tissue-specific transcription of myogenin during mouse 
embryogenesis. Myogenin-lacZ  transgenes trace the 
fate of embryonic cells that activate myogenin transcrip- 
tion and suggest that myogenic precursor cells that mi- 
grate from the somite myotome to the limb bud are 
committed to a myogenic fate in the absence of myo- 
genin transcription. Activation of a myogenin-lacZ 
transgene can occur in limb bud explants in culture, 
indicating that signals required for activation of myo- 
genin transcription are intrinsic to the limb bud and 
independent of other parts of the embryo. These 
results reve~ multiple populations of myogenic precur- 
sor cells during development and suggest the existence 
of regulators other than myogenic helix-loop-helix pro- 
teins that maintain cells in the early limb bud in the 
myogenic lineage. 
T 
HE formation of skeletal muscle during vertebrate de- 
velopment is associated  with the withdrawal of pro- 
liferating myoblasts from the cell cycle, fusion to form 
multinucleate myotubes, and transcriptional  activation of a 
large set of muscle-specific  genes.  While much has been 
learned about the mechanisms that regulate myogenesis in 
vitro, the intrinsic and extrinsic factors that influence  muscle 
differentiation in vivo remain poorly understood. 
Skeletal muscle in vertebrates is derived from the somites, 
which form by segmentation of the paraxial mesoderm  along 
the neural tube (Chevallier et al., 1977; Christ et al., 1977). 
Somite formation in the mouse begins  at rub d post coi- 
turn (dpc) ~  and progresses caudally over a period of several 
days (Tam, 1981). As somites mature, they become compart- 
mentalized, with the dorsal portions forming the dermamyo- 
tome and the ventral portions giving rise to the sclerotome. 
The first signs of muscle differentiation in the mouse are ob- 
served at 10.5 dpc within the myotome, which arises in the 
center of  the somite through migration of  cells from the dor- 
sal medial portion of the dermamyotome.  Limb muscles be- 
gin to form at •11.5  dire of mouse development and are de- 
rived from myogenic progenitor cells that migrate out from 
the ventrolateral  edge of the dermamyotome (Christ et al., 
1978). Studies with chick-quail chimeras indicate that these 
migrating myogenic  progenitors are committed to a skeletal 
I. Abbreviations used in this  paper: CAT, chloramphenieol transferase; dpc, 
days post coitum;  HLH, helix-loop-helix. 
muscle fate, but they do not express muscle markers until 
they reach the limb bud (Christ et al.,  1978; Jacob et al., 
1979). 
The recent cloning of the MyoD family of myogenic regu- 
lators, which can activate muscle differentiation  in tissue 
culture, has provided an opportunity  to analyze the early 
events associated with establishment and maintenance  of  the 
skeletal muscle lineage in vivo. This family of regulatory 
factors, which includes MyoD, myogenin, myf5, and MRF4, 
activates muscle-specific transcription  through binding to a 
DNA consensus sequence known  as an E-box,  which is 
found in the control regions of numerous muscle structural 
genes (for reviews, see Olson, 1990; Weintraub et al., 1991; 
Emerson, 1990). In addition to activating subordinate genes 
associated with terminal differentiation,  members of the 
MyoD family participate  in a complex regulatory circuit in 
which they auto- and cross-activate one anothers' expression 
(Thayer et al., 1989; Braun et al., 1989; Edmondson et al., 
199t).  Thus,  positive  feed-back interactions  have  been 
postulated  to reinforce the expression  of these regulatory 
factors and to provide stability to the myogenic phenotype. 
Each member of the MYOD family exhibits a unique pat- 
tern of expression during development, suggesting that these 
genes  respond to  distinct developmental  cues.  The first 
member of the MYOD family to be expressed during mouse 
embryogenesis is myf5, which appears in the rostal somites 
at ",,8 dpc (Ott et al., 1991). Myogenin transcripts  are de- 
tected in the somite myotome  by day 8.5, followed two days 
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markers of terminal differentiation (Wright et al., 1989; Sas- 
soon et ai.,  1989). MRF4 is expressed transiently in the so- 
mite myotome between days 9 and 12 and is then repressed 
until late stages of development (Hinterberger et al.,  1991; 
Bober et ai.,  1991). In the developing limb bud, myf5 is ini- 
tially detected between 10.5 and 11.0 dpc, with myogenin and 
MyoD appearing about a half-day later.  Although the cells 
that migrate into the limb bud that eventually give rise to 
muscle are committed to a myogenic fate before day 10, these 
cells do not express transcripts for any member of the MyoD 
family (Sassoon et al.,  1989), suggesting that other regula- 
tory factors are responsible for maintaining them in the myo- 
genic lineage. Whether one or more members of the MyoD 
family  are expressed earlier in these cells and are subse- 
quently extinguished during their migration  from the myo- 
tome to the limb bud is unknown. 
In contrast to myf5, MyoD, and MRF4, which are not ex- 
pressed in many skeletal muscle cell lines, myogenin is ex- 
pressed in all differentiated skeletal muscle lines (Wright et 
al., 1989; Edmondson et al., 1989; Braun et ai., 1989), sug- 
gesting that the myogenin gene responds to a common myo- 
genic  regulatory  pathway.  Analysis  of  the  mechanisms 
regulating myogenin  transcription in muscle cells in vitro has 
revealed binding sites for myogenic helix-loop-helix (HLH) 
proteins  and  the  muscle-specific  enhancer  factor  MEF-2 
within the myogenin promoter that mediate muscle-specific 
transcription and positive autoregulation (Edmondson et al., 
1992). 
To begin to define the mechanisms that regulate myogenin 
expression in vivo and to trace the embryonic fate of myo- 
genic  cells  that  activate myogenin transcription,  we have 
created transgenic mice harboring reporter genes linked to 
the myogenin  5' flanking region. Here we show that DNA se- 
quences immediately preceding the myogenin transcription 
initiation  site are sufficient to direct appropriate temporal, 
spatial,  and tissue-specific expression of a linked reporter 
gene  during  embryogenesis.  MyogenindacZ transgenes, 
which trace the fate of cells that have activated myogenin 
transcription,  show that myogenic progenitors that migrate 
from the somite into the developing limb bud arise from a 
population of cells in the myotome that are committed to a 
myogenic  fate  in  the  absence  of myogenin transcription. 
Analysis of myogenin transcription  in isolated limb bud ex- 
plants,  using myogenin-lacZ transgenes,  indicates  that the 
molecules required for activation of myogenin  expression are 
intrinsic to the limb bud and are autonomous of other parts 
of the embryo. 
Materials and Methods 
Plasmids Construction 
Myogenin 5' flanking sequences (Edmondson et al., 1992) were cloned into 
pCAT-basic (Promega Corp., Madison, WI) and pAUGLacZ (kindly pro- 
vided I~y W.  M. Perry, The University  of Texas M. D. Anderson Cancer 
Center,  Houston,  TX).  pMyo1565CAT  was  made  by cloning an XbaI 
(-1565)-HaellI(+18) fragment into the pCAT-basic, which was then linear- 
ized by HindllI and BamHl for microinjection, pMyoI565(-E)CAT contains 
the 5' flanking sequence from -1565 to -18 and was made by cloning an 
Xbal-BanI fragment into the polylinker of pCAT-basic. For injection, a 
HaelI and BamHI fragment of pMyo1565(-E)CAT was made.  pMyo1565 
(-E)LacZ was made by cloning of the XbaI-BanI fragment described above 
into the polylinker of pAUGLacZ and linearized by HindllI and EcoRI di- 
gestion for microinjection, pMyo1565LacZ was made by cloning the XbaI- 
HaelH fragment into the polylinker of the pAUGLacZ, and lineadzed by 
HindllI and EcoRI digestion.  Additional details of the myogenin 5' flanking 
sequences in these constructions have been described (Edmondson et al., 
1992). All plasmids to be injected were purified by double CsC1 centrifuga- 
tion, and the fragments isolated from SeaPlague  (FMC Corp., Rockland, 
ME) agarose gel, phenol/chloroform cleaned,  and passed through a NACS 
column (Life Technologies,  Inc., Gaithersburg, MD). 
Production and Analysis of Transgenic Mice 
Hybrid inbred (C57BL6 x  CBA)F1 mice (Jackson Laboratory, Bar Harbor, 
ME) were  used as stud males, embryo donors, and mature females  for 
breeding.  Outbred ICR mice (Harlan Sprague Dawley, Indianapolis,  IN) 
were used for vasectomized males and pseudopregnant females.  The pro- 
cedure for generating transgenic mice has been described (Hogan et al., 
1986). Stable lines of transgenic mice were maintained by backcrossing to 
founder animals to nontransgenic (C57BL6 x  CBAF1) hybrid mice. Trans- 
gene-positive  animals were identified  by PCR amplification  of tail DNA 
(Hanley and Medic,  1991) or by Southern blot analysis.  Noon of the day 
vaginal plugs are detected  is counted as 0.5 dpe with the diurnal cycle of 
dark from 7:00 PM to 5:00 AM. Embryonic development was also moni- 
tored according to Theiler (1972). Embryos were dissected out by removing 
all the coverings including the arnnion, and fixed in 2 % paraformaldehyde, 
0.2% glutaraldehyde,  in PBS for 30 to 90 rain depending on size. The em- 
bryos were then washed twice in PBS for a total of 30 rain. They were then 
stained with 1 mg/ml X-gal, 2 mM MgCI2, 5 mM K3Fe(CN)6, and 5 mM 
K~e(CN)~ in PBS at room temperature for 12-16 h, after which time they 
were cleared in PBS for more than 10 h and then they were further fixed 
and stored in 4% formaldehyde (Sanes et al., 1991). Whole-mount embryos 
were dehydrated,  cleared, and embedded in paraffin.  Sections 5 #M thick 
were dewaxed and counterstained with hematoxylin and eosin. Different or- 
gans and tissues were isolated from 3-wk old tail-positive  mice for chloram- 
phenicol acetyltransferase  (CAT) assay  as described (Donoghue et al., 
1991). 
CAT activity in extracts of transgenic tissues was measured using 0.1-100 
/~g of extract protein, as described (Donoghue et ai., 1991). All values from 
the CAT assay were normalized to 10 ~g of cellular extract.  Assays were 
linear with respect to time and protein concentration. Activities were deter- 
mined by separating  substrate and product by thin-layer  chromatography 
and counting radioactivity  in the different  species. 
Results 
The Myogenin 5' Flanking Region Directs 
Muscle-specific Expression of  a Linked CAT Gene 
in Transgenic Mice 
To begin to define the DNA sequences that regulate myo- 
genin transcription  in vivo, we generated transgenic  mice 
harboring the transgene pMyo1565CAT, which contains the 
CATreporter  gene linked to a DNA fragment extending from 
+18 to -1565 relative to the myogenin transcription  initia- 
tion site (Fig.  1 a).  Analysis of nine independent  lines of 
transgenic mice revealed three lines that expressed the trans- 
gene in the F1 generation.  In all three lines,  high levels of 
CAT expression were observed in skeletal muscle, with no 
detectable expression in any other tissues examined, includ- 
ing cardiac and smooth muscle (Fig.  1 b). The level of CAT 
expression in skeletal muscle from different transgenic lines 
varied severalfold,  but was in all cases at least 3,000-fold 
higher in skeletal muscle than in nonmuscle tissues. These 
results are consistent with previous studies which showed 
that DNA sequences immediately upstream of the myogenin 
gene were sufficient for muscle-specific transcription  in C2 
muscle cells and chick primary  myotubes (Edmondson  et 
al.,  1992; Salminen et al.,  1991). 
An E-box that binds myogenic HLH proteins with high- 
affinity is located between the TATA element and the tran- 
scription start site of the myogenin gene (Edmondson et al., 
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Figure 1. Muscle-specific expression of myogenin-CATtransgenes. (A) Expression vectors for creation of transgenic mice. Restriction frag- 
ments encompassing the myogenin promoter and extending to the XbaI and Sinai restriction sites at -1565 and -335, respectively, were 
inserted immediately upstream of CAT or/acZ. The proximal promoter contains a MEF-2 site and an E-box (E-l) surrounding the TATA 
box. Constructions lacking E-1 are indicated (-El). Details of the constructions are described in the text. (B) CAT activity was determined 
in extracts of adult mouse tissues from transgenic lines GECAT-31, GECAT-63, and GECAT-43, harboring MyoI565CAT and transgenic 
line GCAT-28, harboring  MyoI565(-E1)CAT. (C) CAT activity was determined  in extracts of adult mouse tissues from transgenic line 
G2CAT-22, harboring Myo335CAT, and transgenic line G2CAT-53, harboring Myo335(-E1)CAT. Values are normalized to the percent con- 
version of substrate to product by 10 #g of protein from the indicated tissue extract. Assays with skeletal muscle extracts were linear in 
the range of 1-100/~g of protein and were diluted sufficiently to allow enzyme activity to be determined quantitatively. Skeletal muscle 
was obtained  from the hind limb, and it was the only tissue that showed activity above background. 
1992).  In cultured muscle cells, this E-box, referred to as 
E-I, has less than a  twofold effect on the level of muscle- 
specific transcription and does not influence the site of tran- 
scription initiation (Edmondson et al.,  1992). To determine 
whether E-1 contributed to myogenin transcription in vivo, 
we generated lines of mice using a derivative of pMyo1565- 
CAT, in which E-1 was deleted (Fig.  1 b). Like the parental 
transgene, this construction, designated pMyo1565(-E1)CAT, 
directed  high-level  expression  of CAT  in  skeletal  muscle 
(Fig.  1 b).  There was no apparent difference in the overall 
level of CAT expression in hind limb muscles from mice har- 
boring MyoI565CAT and MyoI565(-E1)CAT, suggesting that 
E-1 is nonessential for myogenin transcription in adult skele- 
tal muscle. 
We  also  examined  the  expression  of a  CAT transgene 
linked to the 335 bp of DNA preceding the myogenin tran- 
scription initiation site with and without E-1 (Fig.  1 a). As 
with the larger 5' flanking region, CAT expression directed 
by the 335-bp promoter was strictly muscle-specific and was 
not dependent on E-box E-1 (Fig.  1 c). The level of CAT ex- 
pression in these transgenic lines, however, was significantly 
less than that of the lines derived with Myo1565CAT. These 
results suggest that elements required for muscle-specific ex- 
pression are contained within the 335-bp promoter, but that 
elements required for maximal expression may lie between 
-335 and  -1565. 
A iacZ Reporter Gene Linked to the Myogenin 5' 
Flanking Region Recapitulates the Temporal, Spatial, 
and 1~ssue-specific Pattern of  Expression of the 
Endogenous Myogenin Gene During Embryogenesis 
To analyze the temporal and spatial pattern ofmyogenin tran- 
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transgenic mice harboring a/acZ reporter linked to the re- 
gion from +18 to -1565 bp of the myogerdn 5' flarbtfag re- 
gion (Myo15651acZ) (Fig.  1 a). Whole-mount staining for 
lacZ activity revealed high levels of expression of this trans- 
gene by 9.5 dpc in the rostral-most somites (Fig. 2 a), which 
represent the initial site of myogenin mRNA accumulation 
detected by in situ hybridization  (Wright et al,,  1989; Sas- 
soon et al.,  1989). By day 10.5, strong expression  of the 
transgene was detected within more than 30 somites (Fig. 2 
b). This restful-to-caudal progression of transgene expres- 
sion parallels  the pattern of semite maturation and agrees 
with the time course for expression of the endogenous gene. 
Transverse sections through the restful somites of 10.5-d 
embryos showed high levels of transgene expression in the 
central region of the semite, corresponding to the rn)~tome 
(Fig. 3, a and b) and allowed mapping of  individual cells that 
activated myogenin  transcription.  The boundary of  transgene 
expression in the sornite was well defined and did not extend 
beyond the myotomal region, The compartmentalization of 
transgene expression was also evident  in sections through the 
more caudal somites, in which the dermatome, myotome  and 
sclerotome were clearly delineated (Fig. 3 c). 
LacZ staining  became detectable within  mononucleate 
myogenic cells in the limb buds as well as in the visceral 
arches at day 11.5 (Fig. 2 c), at about the same time as the 
endogenous gene becomes activated in these structures (Sas- 
soon et al., t989). Expression of tacZ was observed in the 
forelimbs about a half day bea~ore  the hindlimbs; this is con- 
sistent with the derivation of limb muscles from the somites, 
which show a rostral-to-caudal  pattern of maturation.  High- 
level expression of  lacZ was subsequently observed in newly 
formed  muscle  fibers in the trunk, limbs, and face  and served 
as a marker for the sequential formation of skeletal muscles 
throughout the developing  embryo (Fig.  2).  We detected 
little or no ectopic expression oflacZ in nonmusele cell types 
at any stage of development in mice harboring Myo1565- 
lacZ, with the exception of one line which showed low level 
expression of lacZ in specific regions of the brain (Fig. 2, 
a and b). Identical expression in the somites, lirrfb buds and 
skeletal muscle fibers was observed in transgenic mice that 
were sacrificed in the F0 generation. 
Migrating Myogenic Progenitors  Do Not 
Express Myogenin 
It is well established that skeletal muscle in the limbs arises 
from myogenic progenitor cells that migrate out from the 
ventrolateral aspect of the semite myotome (Christ et al., 
1978). Although these migrating cells are committed to a 
myogenic fate, they do not express transcripts  for the myo- 
genic HLH proteins at detectable levels  (Sassoon  et al., 
1989), which suggests that they are derived from a unique 
population of  semitic cells or that these cells extinguish tran- 
scription of these genes during migration. To distinguish be- 
tween these possibilities,  we analyzed transgenic embryos 
harboring Myo15651acZ  between days 9.5 and 1L5 of devel- 
opment for the presence of lacZ-positive cells in the zone of 
migration  between the semite myotome  and limb bud. LaeZ- 
positive cells were easily detectable in the semite myotomes 
at day 10.5 (Figs. 2 b and 4, a and b), but there was no laeZ 
,staining in the limb buds at that time. By day 11.5, regions 
of  lacZ-positive cells were observed throughout  the limb bud 
(Figs. 2 c and 4 c), LacZ-positive cells were never observed 
within the zone between the somites and the limb bud where 
myogenic precursors are known to migrate before day 11.5. 
Because the lacZ protein has a relatively long half-life and 
was expressed at high levels in cells within the semite myo- 
tome by day 9.5, the enzyme should have marked these 
myogenic precursors if the myogenin gene was indeed tran- 
scribed in these cells before their migration. Indeed, lacZ- 
positive cells appear to migrate from the restful somites to 
the visceral arches at 10.5-11.5 dpc. The failure to detect 
lacZ staining in cells that migrate into the limb bud suggests 
that  these committ~ myogenic cells are derived from a 
population  of cells in the semite myotome that never ex- 
pressed myogenln. 
Myogenin-lacZ Transgenes  Become  Activated in Limb 
Bud Explants 
To determine whether endogenous regulators of myogenin 
transcription could activate myogenin-tacZ  transgenes in the 
limb bud in the absence of  other parts of  the embryo, we iso- 
lated forelimb buds from 10.5 d transgenic embryos harbor- 
ing Myo15651acZ  and placed them in culture. There was no 
detectable lacZ expression within the limb buds at the time 
they were isolated. However, after 4 d in culture, expression 
of lacZ was readily detectable in the distal region of the limb 
bud (Fig. 5). These results confirm that myogenic precursors 
that are destined to form muscle are present in the limb by 
day 10.5, but these cells do not activate myogenin transcrip- 
tion until at least 1 d later. 
Discussion 
Myogenin transcription is activated  when skeletal muscle 
cells are induced to differentiate  by exposure to growth 
factor-deficient medittm, preceding by several hours the ex- 
pression of genes associated with terminal differentiation 
(Wright et al., 1989; Edmondson and Olson, 1989). To be- 
gin to define  the mechanisms regulating myogenin  transcrip- 
tion during embryogenesis, we have analyzed the expression 
of reporter genes linked to the myogenin control region in 
transgenie  mice. Our results show that the cis-acting se- 
quences required for appropriate temporal,  spatial,  and 
tissue-specific transcription of myogenin lie within 1,565 bp 
5' of the gene. When linked to reporter genes such as/acZ, 
these sequences allow mapping at the single cell level of  cells 
in the developing embryo that activate myogenin transcrip- 
tion, and they suggest the existence of  distinct types of myo- 
genic precursors in the semite myotome and limb buds. 
Figure  2. Developmentai  regulation  of  myogeninqacZ  transgenes.  Transgenic  embryos  harboring  Myo15651aeZ  were  stained  for lacZ activ- 
ity. (,4) 9.5 dpc; (B) 10.5 dpc; (C) 1t.5 dpe; (D) 12.5 dpe; (E) 13.5 dpc. Embryos  in D and E harbor Myo1565(-E1)laeZ,  which shows 
the same pattern of expression as the transgene  with El at these developmental  stages. Transverse  sections  through  the embryos  in B and 
C are shown in Figs. 3 and 4. 
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Activate Myogenin Transcription Until They 
Reach the Limb Bud 
Myogenin expression is first detected in the somite myotome 
at 8.5 dpc, a half day later than myf5 and 2 d earlier than 
MYOD (Wright et al.,  1989;  Sassoon et al., 1989; Bober et 
al., 1991; Ott et al.,  1991). Skeletal muscle in the limbs is 
derived from the  somites.  However,  transcripts  encoding 
myogenic HLH proteins are not detected in the developing 
limb bud until day 11, despite the fact that cells within this 
region are committed to a myogenic fate before that time. At 
least two explanations could account for the lack of expres- 
sion of myogenic regulatory factors in committed myogenic 
cells within the limb bud. These cells could be derived from 
a population of cells within the somite myotome that fails to 
express myogenic HLH proteins prior to migration to the 
limb bud and are committed to a myogenic fate by regulatory 
proteins that are as yet unidentified. Alternatively, myogenic 
cells could extinguish expression of the myogenic regulators 
during migration, but previous expression of these factors 
may have committed them to a myogenic fate. Because of the 
short half-lives of  myogenin  and MyoD mRNAs and proteins 
(Thayer et al.,  1989;  Edmondson et al.,  1991), these gene 
products  would  be  expected  to  disappear  rapidly  from 
migrating precursors  if transcription  of these  genes  was 
repressed when cells exit the somite myotome and enter the 
limb bud. 
Using the myogenin control region linked to lacZ, we 
show that the lacZ protein, which exhibits a long half life in 
vivo, is expressed at high levels in the somite myotome be- 
fore day 9.5, but is not detectable in the limb buds until day 
11.5. The absence of lacZ expression in myogenic precursor 
cells that migrate into the limb bud well before day 11.5 indi- 
cates that myogenin transcription has not been previously ac- 
tivated in these cells and suggests that cells that contribute 
to skeletal muscle of the limbs are derived from a unique 
population of cells in the somite, distinct from that which ac- 
tivates myogenin transcription in the myotome. 
We also analyzed myogenin transcription in limb bud ex- 
plants  from transgenic  mice  harboring  a  myogenin-lacZ 
transgene. There was no detectable myogenin transcription 
in limb buds until day 11.5, but if limb bud explants from 
10.5 d embryos were incubated in vitro for several days, the 
myogenin-lacZ transgene became activated. These results 
confirm that cells destined to become muscle are present in 
the limb at least 1 d before the activation of myogenin tran- 
scription. These results also suggest that the mechanism that 
specifies myogenin expression is already in place in the limb 
by day 10.5 and requires no further contribution from other 
parts of the embryo. 
If cells committed to a myogenic fate are present in the 
early limb bud, but these cells do not express members of 
the MyoD family, how might they be maintained in the lin- 
eage? We favor the notion that there may be additional regu- 
lators  that  participate  in  myogenic lineage  commitment, 
which could be operating in these cells. Indeed, considerable 
Figure 3. Myogenin-lacZ  expression within the somite myotorne. 
Transgenic embryos harboring Myo15651acZ were analyzed for 
laeZ expression  in sections  through the somites. (A) Transverse sec- 
tion through the rostral somites of a 10.5 d transgenic embryo. (B) 
Higher magnification of A.  (C)  Transverse section through the 
caudal somites of a  10.5 d transgenic embryo. NT, neural tube; 
DA, dorsal aorta; NC, notochord; m, myotome; d, dermatorne; s, 
sclerotome. 
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the level of the forelimb bud of a 10.5 d transgenic embryo harboring Myo15651acZ  from Fig. 2 B. (B) High magnification of the region 
in the box (A). (C) Transverse section through the level of  the forelimb bud of an 11.5 d transgenic embryo from Fig. 2 C. NT, neural tube. 
evidence is accumulating to suggest the existence of regula- 
tory factors that can control myogenic lineage commitment 
in the absence of myogenic HLH proteins. Caenorhabditus 
elegans mutants, deficient for MyoD, for example, are able 
to express skeletal muscle-specific genes (Chen et al., 1992). 
Similarly, expression of activated Ras and Fos or incorpora- 
tion of the thymidine analog 5-bromo-2'deoxyuridine into 
myoblast DNA extinguishes expression of myogenic HLH 
proteins, but cells under these conditions remain committed 
Figure 5. Expression of myogenin-lacZ transgenes in limb bud ex- 
plants. Forelimb buds were dissected from 10.5 d transgenic em- 
bryos harboring Myo15651acZ  and were placed in culture in DME 
containing 10% FBS and 3% chick embryo extract. There was no 
detectable expression of lacZ in the limb buds at the time they were 
isolated. 4 d after incubation in culture, limb buds were stained for 
lacZ. High-level expression of lacZ is detected in the distal region 
of the limb bud. (p, d, a) Proximal, distal, and anterior regions of 
the limb, respectively. 
to  a  myogenic fate (Lassar  et al.,  1989;  Tapscott et al., 
1989).  Mutational  analysis  of the myogenin promoter  in 
transgenic mice should permit the identification of cis-acting 
sequences, and eventually trans-acting factors, responsible 
for initial activation of myogenin transcription in the limb 
bud. Such regulatory factors would be likely candidates for 
regulators of myogenic lineage commitment. 
Analysis of the myogenin promoter in muscle cells in cul- 
ture has  revealed that muscle-specificity and positive au- 
toregulation are dependent on a binding site for the muscle- 
specific enhancer factor MEF-2 in the myogenin promoter 
(Edmondson et al., 1992). The temporal and spatial regula- 
tion of MEF-2 expression during embryogenesis has not yet 
been defined, but it is possible that MEF-2 may contribute 
to  myogenin transcription  in  the  somite  myotome  and 
limb bud. 
Myogenin-lacZ 7h2nsgenes  Reveal Multiple Myogenic 
Celt ~s  in the Somite Myotome and Limb Buds 
The existence of two distinct populations of myogenic pro- 
genitors that give rise to muscles of the trunk and limbs is 
consistent  with  recent  studies  of Ordahl  and  LeDouarin 
0991). By somite grafting experiments in chick-quail chi- 
meras, they showed that cells in the lateral portion of the so- 
mite contribute to muscles of the limbs whereas cells in the 
medial region of the somite contribute to the axial muscles 
of the trunk. The fate of cells in these two regions are plastic 
and can be altered when transplanted to the opposite region. 
Our results indicate that transcription ofmyogenin in the my- 
otome may be an initial marker of the axial muscle precur- 
sors, but not the limb muscle precursors. 
The control region for MyoD was also analyzed recently 
in transgenic mice (Goldhammer et al.,  1992). In contrast 
to myogenin, in which the regulatory region lies within the 
proximal promoter, the MyoD control region is located ,x,15 
kb upstream of  the gene (Goldhammer et al., 1992). Expres- 
sion ofMyoD-lacZ  transgenes has been reported for a single 
time point during development, and the regulatory elements 
have been mapped only to a 4-kb region, so it remains to be 
determined whether this region is necessary and sufficient 
for the full pattern of MyoD transcription throughout em- 
bryogenesis. 
Cheng et aL Activation of Myogenin Transcription In Vitro  1655 The muscle-specificity of and autoregulatory  interactions 
among members of the MyoD family of myogenic regulatory 
genes suggest that commonalities may exist in the mecha- 
nisms regulating these genes. However, each member of this 
regulatory gene family also exhibits distinct aspects of regu- 
lation  which  are  likely  to  arise  from unique regulatory 
mechanisms.  Further analysis  of the control  regions that 
govern expression in somites and limb buds of these different 
genes should permit the details of the myogenic regulatory 
circuit to be defined. 
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